Skip to main content
  • UMB Launches new Copyright License Agreement

    The New SEEK License Option is copyrighted material to screen for several common problems that are risk factors for child maltreatment.

    Learn More
  • New Harpoon Medical Surgical Tool for Mitral Valve Repair Shows Success in 1st Human Clinical Study

    Device Simplifies Valve Repair, Avoids Open Heart Surgery

    Read More
  • ACIP Greenlights PaxVax's Cholera Vaccine

    The vaccine, dubbed Vaxchora, is the only licensed cholera vaccine in the U.S. and the only single-dose cholera vaccine in the world.

    Read More
  • FDA Approves Vaccine for Cholera Invented and Developed at University of Maryland School of Medicine

    Vaccine Is the Only One Approved in the U.S. for Protection Against Cholera

    Read More
  • Maryland Commerce Convenes Partners to Form Centers of Excellence in Biomanufacturing, Transformative Medicine

    Johns Hopkins University, University of Maryland, Baltimore and University of Maryland, College Park to collaborate with state on commercialization of transformative medicines, devices

    Read More
  • Visisonics Hits Market with 3-D Sound Technology


    Technology Spun from University of Maryland Currently Licensed by Oculus

    Read More
  • Hot Technologies Available for Licensing

    UM Ventures is organized to move research outcomes into products and services, tools and diagnostics that will benefit society.

    Learn More

Receive Tech Alerts

Sign up to receive the UM Ventures e-newsletter, new technology announcements, and other news.

Select Your Interest(s)
University of Maryland, College Park
University of Maryland, Baltimore

UM Ventures is a joint initiative of the University of Maryland, Baltimore and University of Maryland, College Park to commercialize technologies and expand industry collaboration.

Learn More